GSK3beta’s involvement in AD is further supported by the fact that AD patients have elevated levels of GSK3beta [54, 55] and that familial AD-associated protein PS1 helps localize the kinase to tau[56]. The gene discussed is MAPT; the disease is Alzheimer disease.